Hurry up lab, page-93

no dramas at all mate.

As far as im aware, quarterly reports can only shed light on whats previously been provided as a market sensitive announcement prior, but can go into further details.

My thinking being is that assays may be received, but management should ideally hold the right to release them at a time that suits. In this case, they could well be waiting for clarity on the OD issue and hope to release the information in one announcement. If they were to release assays prior, the waters are still muddied and may deter prospective buyers